Pakistan, China Deepen Pharma Ties as Islamabad Hosts B2B Investment Conference

Pakistan, China Deepen Pharma Ties as Islamabad Hosts B2B Investment Conference

Islamabad opened a two-day Pakistan–China health care investment conference, bringing together leading Pakistani pharmaceutical, health care and biotechnology companies with Chinese investors, manufacturers, technology providers and industry leaders, on Friday.

The Pakistan–China Pharmaceutical & Healthcare B2B Investment Conference 2026 was jointly organized by the Special Investment Facilitation Council (SIFC), Pakistan’s health ministry and the Drug Regulatory Authority of Pakistan to promote investment, innovation and strategic partnerships in the pharmaceutical, health care and biotechnology sectors.

The gathering includes business-to-business meetings, networking opportunities, and dedicated investment sessions to facilitate engagement between companies from both countries, state broadcaster Radio Pakistan reported.

Turnout is substantial: around 160 Chinese firms, represented by nearly 180 delegates, are expected to take part, alongside 340 Pakistani businessmen and business ventures.

Read More: FPCCI Marks 75 Years of Pakistan-China Diplomatic Ties

Kamal used the occasion to highlight a structural gap in Pakistan’s drug manufacturing sector. While the country produces 85% of its own medicines, it still imports 90% of the raw materials needed to make them; a dependency officials hope Chinese investment and technology transfer can help close through joint ventures and local production partnerships.

The conference fits into a broader pattern of Chinese economic engagement with Pakistan. China remains a major ally and investor in Pakistan, having pledged more than $65 billion toward road, infrastructure and development projects, in addition to joint ventures undertaken by several Chinese private manufacturers in the country.

For Islamabad, the event also reflects a shift in economic priorities. Pakistan is pursuing economic stabilization under a $7 billion IMF program, with policymakers increasingly focused on reviving industrial activity, attracting investment and boosting exports.

Organizers say the sessions are designed to have lasting impact beyond the two days of talks. In an earlier statement, the SIFC said the conference is expected to facilitate meaningful business engagements that support modernization of Pakistan’s health care ecosystem while enhancing the competitiveness of its pharmaceutical industry.

The SIFC said the conference is expected to further reinforce the longstanding strategic partnership between Pakistan and China by encouraging long-term industrial collaboration and unlocking new avenues of investment.

News Desk
+ posts